Brain mapping study aims to protect critical functions during tumor surgery

NCT ID NCT01535430

Recruiting now Knowledge-focused Sponsor: University of Nebraska Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study uses brain mapping techniques like fMRI and MEG before, during, and after surgery to see how brain functions like movement and speech reorganize in people with brain tumors. Researchers hope to improve surgical planning and preserve important brain functions. The study involves 75 adults with brain tumors near critical brain areas.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better surgical planning and preservation of important brain functions during tumor removal.
What could go wrong: This is an observational study, not a treatment trial. It may not directly benefit participants, and results may not apply to all brain tumor patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC BRAIN TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain cancer metastatic malignant neoplasm in the brain primary brain neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METASTATIC BRAIN TUMOR PRIMARY BRAIN TUMOR

Contacts and locations

Locations

University of Nebraska Medical Center
RECRUITING

Omaha, Nebraska, 68198, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.